AI Article Synopsis
- The EPIC consortium is a collaborative group of experts from diverse fields, including microbiology, infectious diseases, chemistry, and bioinformatics.
- Their primary focus is to explore effective methods for data mining carbapenemase inhibitors and translating that data into practical experiments.
- They aim to inspire the scientific community to develop new strategies for efficiently discovering carbapenemase inhibitors, ensuring timely results that are cost-effective.
Article Abstract
The EPIC consortium brings together experts from a wide range of fields that include clinical, molecular and basic microbiology, infectious diseases, computational biology and chemistry, drug discovery and design, bioinformatics, biochemistry, biophysics, pharmacology, toxicology, veterinary sciences, environmental sciences, and epidemiology. The main question to be answered by the EPIC alliance is the following: "What is the best approach for data mining on carbapenemase inhibitors and how to translate this data into experiments?" From this forum, we propose that the scientific community think up new strategies to be followed for the discovery of new carbapenemase inhibitors, so that this process is efficient and capable of providing results in the shortest possible time and within acceptable time and economic costs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456441 | PMC |
| http://dx.doi.org/10.3390/ijms23179746 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!